1. Home
  2. MGNI vs AMPH Comparison

MGNI vs AMPH Comparison

Compare MGNI & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGNI
  • AMPH
  • Stock Information
  • Founded
  • MGNI 2007
  • AMPH 1996
  • Country
  • MGNI United States
  • AMPH United States
  • Employees
  • MGNI N/A
  • AMPH N/A
  • Industry
  • MGNI Computer Software: Programming Data Processing
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • MGNI Technology
  • AMPH Health Care
  • Exchange
  • MGNI Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • MGNI 1.7B
  • AMPH 2.5B
  • IPO Year
  • MGNI N/A
  • AMPH 2014
  • Fundamental
  • Price
  • MGNI $12.94
  • AMPH $51.45
  • Analyst Decision
  • MGNI Strong Buy
  • AMPH Buy
  • Analyst Count
  • MGNI 11
  • AMPH 4
  • Target Price
  • MGNI $16.95
  • AMPH $63.00
  • AVG Volume (30 Days)
  • MGNI 1.3M
  • AMPH 268.7K
  • Earning Date
  • MGNI 11-07-2024
  • AMPH 11-06-2024
  • Dividend Yield
  • MGNI N/A
  • AMPH N/A
  • EPS Growth
  • MGNI N/A
  • AMPH 62.07
  • EPS
  • MGNI N/A
  • AMPH 3.15
  • Revenue
  • MGNI $649,216,000.00
  • AMPH $712,891,000.00
  • Revenue This Year
  • MGNI $0.26
  • AMPH $18.04
  • Revenue Next Year
  • MGNI $10.75
  • AMPH $4.41
  • P/E Ratio
  • MGNI N/A
  • AMPH $16.26
  • Revenue Growth
  • MGNI 7.50
  • AMPH 31.80
  • 52 Week Low
  • MGNI $6.46
  • AMPH $36.56
  • 52 Week High
  • MGNI $15.92
  • AMPH $65.92
  • Technical
  • Relative Strength Index (RSI)
  • MGNI 54.59
  • AMPH 59.40
  • Support Level
  • MGNI $12.35
  • AMPH $49.38
  • Resistance Level
  • MGNI $13.11
  • AMPH $51.84
  • Average True Range (ATR)
  • MGNI 0.42
  • AMPH 1.25
  • MACD
  • MGNI 0.11
  • AMPH 0.10
  • Stochastic Oscillator
  • MGNI 63.58
  • AMPH 78.90

About MGNI Magnite Inc.

Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: